Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-560P is a non-functional, processed pseudogene derived from the gene encoding U6 small nuclear RNA (U6 snRNA). U6 snRNA is a highly conserved non-coding RNA that forms part of the spliceosomal machinery necessary for the splicing of pre-mRNA in eukaryotic nuclei[1][3]. Numerous U6 snRNA pseudogenes exist in mammalian genomes, typically lacking promoter elements or other sequences required for expression, and thus do not contribute to splicing or have independent biological activity[3][4]. Pseudogenes like RNU6-560P are generally considered "genomic fossils" rather than true molecular targets or active regulators[4]. There is currently no evidence of therapeutic, diagnostic, or pharmacological relevance for RNU6-560P. *Additional context:* - Functional U6 snRNA is essential for the major spliceosome's catalytic activity but pseudogenes do not contribute to spliceosome function[1][3]. - Most U6-derived pseudogenes are not transcribed, and even when RNA is made, it is typically unstable and non-functional[3][4]. - Pseudogenes are sometimes co-opted for regulatory roles by the genome (as in some long non-coding RNAs[4]), but there is no such evidence for RNU6-560P. This entry does not represent a true drug target, therapeutic receptor, or disease biomarker. The entity is best classified as a pseudogene of U6 small nuclear RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 560, pseudogene (RNU6-560P).